The Role of In Vitro Diagnostics (IVD) in Saudi Arabia's Healthcare System

Date :
  • December 2015

Saudi Arabia’s healthcare system currently relies heavily on government funding, which accounts for 65% healthcare spending in the country. Healthcare trends in Saudi Arabia's, e.g. demographic shifts, high incidence rates of lifestyle related diseases, growing demand for private healthcare services, and strategic investments made by the government have driven demands for in vitro diagnostic (IVD) devices. Solidiance co-developed this exclusive white paper with Kind Abdulaziz Medical City and Abbott Diagnostics, highlighting the contribution, value and future of in vitro diagnostics in Saudi Arabia’s healthcare system. According to the report, the future looks bright for IVD in Saudi Arabia, however it depends on how fast it can be adopted and implemented in order to benefit the government, healthcare players seeking to improve and invest on the sector, and also the people.

This white paper aims to address these main questions :

  • 01. What IVD contributes to improve the combat of, and cure for, diseases worldwide?
  • 02. What are the value, contributions and future of IVD in Saudi Arabia's healthcare system?
  • 03. How the government and private sector address the higher demand of IVD?

Download White Paper